Investors & Media

Corporate Governance

International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called human parthenogenetic activation that promises to significantly advance the field of regenerative medicine.
Andrey Semechkin, PhD., Chief Executive Officer



Committee Composition

  Audit Committee Compensation Committee Governance Committee
Independent Directors
Donald Wright
Paul Maier
Inside Directors
Andrey Semechkin, PhD.  
Russell Kern, PhD.